Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Statement re Board Changes

25 Oct 2018 07:01

Board Changes

Dublin, London, 25 October 2018: C&C Group plc (‘C&C’ or the 'Group’), a leading manufacturer, marketer and distributor of branded cider, beer, wine and soft drinks today announces a series of changes to its Board of Directors.

Having overseen the smooth transition to a new Chairman, Richard Holroyd the Senior Non-Executive and Director since 2004 has informed the Board of his wish to step down and leave the Board in the new year. Geoffrey Hemphill a Non-Executive Director since 2017 has also informed of his intention to stand down from the Board to concentrate on other business interests.

On his appointment as Chairman Stewart Gilliland undertook a review of the composition of the Board to ensure that it has the right balance of skills and experience particularly in light of the strategically important acquisition of Matthew Clark and Bibendum.

The conclusion of this review was that the International Division would no longer be represented at the Group Board and the composition of the Board would be best comprised of a Chairman, 3 Executives (CEO, CFO and COO) and a reduced number of Non-Executive Directors.

Accordingly, Joris Brams as an Executive Director will stand down from the Board. Jim Clerkin, Vincent Crowley and Emer Finnan all Non-Executive Directors will remain in role and a search for new Non-Executive Directors with the appropriate skills and experience has commenced.

We are very grateful to Richard, Geoffrey and Joris for the individual contribution each of them has made to the Group’s long-term development.

ENDS

Contacts

C&C Group plc

Stephen Glancey | Group Chief Executive

Jonathan Solesbury | Chief Financial Officer

Joe Thompson | Head of Investor Relations

Tel: +44 7980 844 580

Email: Joe.Thompson@candcgroup.com

FTI Consulting

Mark Kenny/Jonathan Neilan/Paddy Berkery

Tel: +353 1 765 0886

Email: CandCGroup@fticonsulting.com

Novella Communications

Tim Robertson/Toby Andrews

Tel: +44 203 151 7008

Email: TimR@novella-comms.com

About C&C Group plc

C&C Group plc is a premium drinks company which owns, manufactures, markets and distributes branded beer, cider, wine, soft drinks and bottled water. C&C Group brands include: Bulmers the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of super-premium and craft ciders and beers. C&C Group also owns and manufactures Woodchuck, a leading craft cider brand in the United States and manufactures and distributes a number of 3rd party international beer brands in Scotland and Ireland. C&C is also a leading drinks wholesaler in the UK and Ireland, where it operates under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands. C&C Group has a minority investment in the Admiral Taverns tenanted pub group, which owns over 850 pubs across England & Wales. C&C Group is headquartered in Dublin with manufacturing operations in Co.Tipperary, Ireland; Glasgow, Scotland; and Vermont, US. C&C Group plc is listed on the Irish and London Stock Exchanges.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181024006006/en/

Copyright Business Wire 2018

Date   Source Headline
5th Jul 20242:50 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSAnnual Financial Report
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20241:52 pmRNSResponse to Shareholder Letter
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20249:45 amRNSHolding(s) in Company
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSPY Accounting Adjustments and Directorate Changes
7th Jun 20247:00 amRNSSummary of FY2024 Unaudited Financial Performance
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20244:45 pmRNSNotice of Results
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20243:00 pmRNSBlock listing Interim Review
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20244:15 pmRNSTotal Voting Rights
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20244:48 pmRNSBoard Committee Changes
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20245:50 pmRNSDirector/PDMR Shareholding
15th May 20247:00 amRNSHolding(s) in Company
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTiming of FY2024 Full Year Results
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.